| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 180 | $0.35 | $62.25 $62.25 (0%) | 🛒 Add to cart |
| 360 | $0.31
Best per cap | $124.50 $111.45 (10%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.67 | $40.16 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $60.24 $54.22 (10%) | 🛒 Add to cart |
| 120 | $0.56 | $80.33 $67.27 (16%) | 🛒 Add to cart |
| 180 | $0.53 | $120.49 $95.39 (21%) | 🛒 Add to cart |
| 270 | $0.51 | $180.73 $137.56 (24%) | 🛒 Add to cart |
| 360 | $0.50
Best per cap | $240.98 $179.73 (25%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
Fluoxetine: Expert Treatment for Depression and Anxiety Disorders
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) widely prescribed for the management of major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa. As a first-line pharmacological intervention, it functions by increasing serotonin levels in the brain, which helps regulate mood, reduce anxiety, and improve overall emotional stability. Its well-established efficacy, favorable safety profile, and extensive clinical history make it a cornerstone in psychiatric treatment protocols worldwide. Features Active ingredient: Fluoxetine hydrochloride Available in 10 mg, 20 mg, and 40 mg oral capsules, as well as liquid formulation Selective serotonin reuptake inhibitor (SSRI) class Half-life of 4–6 days (longer for its active metabolite norfluoxetine) FDA-approved for multiple psychiatric and behavioral conditions Bioavailability of approximately 72% Peak plasma concentration within 6–8 hours Benefits Effectively alleviates symptoms of major depressive disorder Reduces frequency and intensity of panic attacks Helps manage obsessive-compulsive behaviors and intrusive thoughts Supports recovery in bulimia nervosa by reducing binge-eating and purging behaviors Improves overall mood stability and daily functioning Long half-life supports consistent therapeutic levels and simplifies dosing Common use Fluoxetine is primarily indicated for the treatment of major depressive disorder (MDD) in adults and pediatric patients aged 8 years and older.
Abilify: Atypical Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity in the brain, reducing symptoms such as hallucinations, delusions, and mood swings while minimizing certain side effects commonly associated with first-generation antipsychotics.
Amaryl: Advanced Glycemic Control for Type 2 Diabetes
Amaryl (glimepiride) is a second-generation sulfonylurea oral antidiabetic medication designed to support the management of type 2 diabetes mellitus. By stimulating insulin release from pancreatic beta cells and increasing peripheral tissue sensitivity to insulin, it effectively helps lower blood glucose levels. It is commonly prescribed as part of a comprehensive treatment plan that includes diet, exercise, and, when necessary, other glucose-lowering agents. Suitable for adult patients, Amaryl offers a reliable therapeutic option for those struggling to achieve target HbA1c levels through lifestyle modifications alone.
Amitriptyline: Effective Relief for Chronic Pain and Depression
Amitriptyline is a tricyclic antidepressant (TCA) with a well-established history in managing major depressive disorder, neuropathic pain, and migraine prophylaxis. It functions by inhibiting the reuptake of serotonin and norepinephrine, modulating central nervous system activity to alleviate symptoms and improve quality of life. Its efficacy, supported by decades of clinical use, makes it a trusted option for specialists seeking durable therapeutic outcomes. Features Chemical class: Tricyclic antidepressant (dibenzocycloheptene derivative) Available forms: Oral tablets (10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg) Mechanism: Serotonin and norepinephrine reuptake inhibition; also exhibits anticholinergic, antihistaminic, and alpha-adrenergic blocking properties Bioavailability: Approximately 30–60% following oral administration Half-life: 10–28 hours; active metabolite nortriptyline has a half-life of 18–44 hours Metabolism: Hepatic, primarily via CYP2D6 and CYP2C19 isoenzymes Excretion: Urine (mostly as metabolites) Benefits Provides significant relief from symptoms of major depressive disorder Effectively reduces neuropathic pain, including diabetic neuropathy and postherpetic neuralgia Decreases frequency and severity of chronic migraine and tension-type headaches Improves sleep architecture due to sedative properties, beneficial for patients with comorbid insomnia Offers a cost-effective treatment option compared to newer antidepressants May be used off-label for conditions such as fibromyalgia, irritable bowel syndrome, and interstitial cystitis Common use Amitriptyline is primarily indicated for the treatment of major depressive disorder in adults.
Anafranil: Restoring Balance in Treatment-Resistant OCD
Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition, approved for the treatment of obsessive-compulsive disorder (OCD). It is recognized for its efficacy in cases where first-line treatments have proven insufficient. By modulating neurotransmitter activity in the central nervous system, Anafranil helps reduce the frequency and intensity of obsessive thoughts and compulsive behaviors. Its well-established pharmacokinetic profile and decades of clinical use make it a cornerstone in psychopharmacology for severe OCD and related anxiety conditions.
Androxal: Clinically Validated Testosterone Restoration Therapy
Androxal (enclomiphene citrate) represents a significant advancement in the treatment of male hypogonadism, specifically addressing secondary hypogonadism by stimulating the body’s endogenous testosterone production. Unlike exogenous testosterone replacement therapies, which can suppress natural hormone synthesis and impair fertility, Androxal works through a selective estrogen receptor modulator (SERM) mechanism to promote the hypothalamic-pituitary-gonadal (HPG) axis. This results in increased luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, thereby encouraging testicular Leydig cells to produce physiologic levels of testosterone.
Armod: Advanced Wakefulness for Enhanced Cognitive Performance
Armod is a prescription medication containing Armodafinil, the R-enantiomer of modafinil, designed to promote wakefulness in individuals with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. As a central nervous system stimulant, it functions by altering the natural chemicals (neurotransmitters) in the brain that regulate the sleep-wake cycle. Unlike traditional stimulants, Armodafinil offers a more refined pharmacological profile with a longer half-life, providing sustained alertness without the pronounced peaks and troughs associated with other agents.
Atarax: Expert Relief for Anxiety and Itching
Atarax (hydroxyzine hydrochloride) is a first-generation antihistamine with anxiolytic, sedative, and antipruritic properties, widely prescribed in clinical practice for its dual efficacy in managing anxiety disorders and allergic pruritus. As a histamine H1-receptor antagonist, it operates centrally to alleviate symptoms by modulating neurotransmitter activity, offering a non-addictive alternative to benzodiazepines for short-term anxiety management. Its well-established safety profile and rapid onset of action make it a versatile option in both psychiatric and dermatological contexts, particularly for patients requiring adjunctive therapy or those with contraindications to newer agents.
Bystolic: Advanced Beta-Blocker Therapy for Hypertension Control
Bystolic (nebivolol) is a beta-blocker medication specifically designed for the management of hypertension. It represents a modern therapeutic option within its class, offering a unique pharmacological profile that combines beta-1 adrenergic receptor blockade with vasodilatory properties. This dual mechanism of action allows for effective blood pressure reduction while potentially mitigating some of the undesirable effects associated with older generation beta-blockers. Clinicians often consider Bystolic for patients requiring a well-tolerated antihypertensive agent, particularly those who may benefit from its hemodynamic and metabolic profile.